In accordance with a brand new examine revealed in BMC Psychiatry, solely 4.9% of sufferers who had been prescribed antipsychotics for his or her psychiatric sickness and had proof of tardive dyskinesia (TD) had TD recorded correctly of their digital well being data, supporting the concept that TD is commonly underreported and misdiagnosed and, due to this fact, not handled appropriately.1
But, TD is a well-established hostile impact of antipsychotic drugs and is commonly irreversible. The well-described hyperkinetic and infrequently dramatic involuntary actions can contain any of the estimated 650 skeletal muscle mass of the human physique, together with the diaphragm and pharynx. In addition to inflicting noticeable and infrequently dramatic involuntary actions, these actions typically trigger important purposeful impairment, which varies considerably from affected person to affected person. Typically the affected person is unaware of those actions, and it isn’t unusual for a affected person’s buddy, member of the family, coworker, or perhaps a stranger to convey these actions to the affected person’s consideration.
TD was first described within the medical literature in 1957,2,3 only a few years after the very first antipsychotic treatment, chlorpromazine, was launched in the USA. Regardless of tireless medical analysis, it wasn’t till 2017 that 2 vesicular monoamine transporter 2 (VMAT2) inhibitors—deutetrabenazine4 and valbenazine5—had been accepted by the US Meals and Drug Administration as the primary evidence-based efficient therapies. This 60-year hole seemingly contributed to the progressive lower in screening, documenting, and discussing the trigger and course of TD with sufferers.
The presumed pathophysiological mechanism of TD by antipsychotics is the antagonism of dopamine-2 receptors (D2Rs) within the dorsal striatum of the human mind, whereas antagonism of those similar receptors within the ventral striatum is believed to enhance psychotic signs, therefore the time period antipsychotic. Nonpsychiatric drugs corresponding to metoclopramide (Reglan; used for the therapy of gastroesophageal reflux illness, gastroparesis, and as an antiemetic) and prochlorperazine (Compazine; used as an antiemetic) share this property of D2R antagonism and exhibit comparable dangers for TD.
The VMAT2 Inhibitors
It was a giant deal when VMAT2 inhibitors had been accepted for the therapy of TD. The American Psychiatric Affiliation up to date their follow pointers for the therapy of schizophrenia in 2020 and really helpful “that sufferers who’ve average to extreme or disabling tardive dyskinesia related to antipsychotic remedy be handled with a reversible inhibitor of the vesicular monoamine transporter 2.”6
There was a lot to find out about TD and its subtleties since its approval. To complicate issues, the sphere of drugs, the FDA lumped a minimum of 24 completely different motion issues into the class of extrapyramidal signs (EPS) with no differentiation concerning etiology and various therapies. Even as we speak, the time period EPS is ubiquitously used to outline the presence of any medication-induced motion dysfunction. (I urged the time period EPS is antiquated and must be retired in a earlier editorial,7 but it surely stays very a lot entrenched in our nosology.)
Curiously, anticholinergic drugs, together with benztropine, diphenhydramine, and trihexyphenidyl, are generally used to deal with all antipsychotic-induced motion issues even supposing they make TD worse and haven’t any profit for akathisia. Equally, the VMAT2 inhibitors can convey out a vulnerability to Parkinson illness (PD), or if PD is already current, they’ll make it worse.
The AIMS Examination
Establishing a pre-antipsychotic motor system baseline, ongoing screening for TD, and monitoring TD as soon as it seems are important elements of fine evidence-based follow.
The Irregular Involuntary Motion Scale (AIMS) examination is at present the gold normal monitoring scale that’s used to ascertain a baseline earlier than initiating an antipsychotic treatment, in addition to to detect the onset of any TD and observe its worsening or enchancment. Initially developed by the Nationwide Institute of Psychological Well being to be used in analysis, clinicians quickly adopted the AIMS, and it’s the most utilized scale for evaluating and managing TD within the US in addition to in scientific trials and analysis.8
The AIMS consists of 12 objects, however solely the primary 7 questions charge motion severity in numerous muscle teams. Every of those teams is rated from 0 (no actions) to 4 (extreme actions), giving a complete numeric vary from 0 (no actions) to twenty-eight (extreme actions in all 7 muscle areas). The collective score of those 7 objects is the AIMS dyskinesia complete rating (AIMS DTS).
Importantly, a person could have an AIMS DTS of 5 but meet the usual for therapy with a VMAT2 inhibitor, whereas one other particular person’s rating could also be 10, but no therapy is indicated. How can this be? Let’s evaluation a couple of case examples.
Case 1
“Ms Robbins” is 49 years outdated and works as a financial institution teller. She has been on an antipsychotic treatment to deal with her bipolar dysfunction for 10 years, leading to stability of temper signs that had been beforehand poorly managed.
Ms Robbins presents to your workplace for a follow-up go to. She had a current encounter along with her supervisor after a number of financial institution clients reported that they noticed frequent eye blinking and a few lip actions throughout their financial institution transactions along with her. Later at dwelling, she requested her husband and grownup kids whether or not they seen any actions. They confirmed some of these actions, noting they appeared to be rising over the previous a number of months.
After performing an AIMS examination, Ms Robbins scores a 3 (average) on the merchandise for muscle mass of facial features attributable to notable eye blinking, and a 2 (gentle) on the merchandise for lip actions, giving her an AIMS DTS of 5.
Upon additional dialogue, Ms Robbins stories elevated nervousness and unhappiness about these actions, and she or he is nervous about her job. Moreover, she stories she is attending fewer social occasions out of embarrassment. She turns into tearful and is visibly distressed in the course of the dialog. She doesn’t need to change any of her present drugs and asks what therapy choices can be found.
Case 2
“Mr Jones” is 45 years outdated and works the night time shift as a safety guard at a big workplace complicated. He has been on an antipsychotic treatment to deal with schizoaffective dysfunction, bipolar kind, for 12 years. He had a number of hospitalizations for psychotic and manic decompensations in his 20s, however he has accomplished nicely over the previous 10 years, which you attribute each to his treatment adherence and minimal psychosocial stressors. Mr Jones is in a long-term relationship and enjoys the quietude and monetary stability of his job.
You carry out his annual AIMS examination, and Mr Jones scores a 2 (gentle) on tongue, lips, jaw, fingers, and ft, leading to an AIMS DTS of 10.
Upon additional dialogue, Mr Jones denies misery from these actions. Though each he and his associate have seen a few of these actions, he prefers to depart therapy as is and easily enhance monitoring with extra frequent AIMS exams.
Affect of Actions
These 2 circumstances spotlight the significance of balancing the relative goal AIMS DTS rating with the person’s expertise and the way actions impression their day-to-day life. Taking a look at AIMS DTS, Mr Jones’ rating was twice as excessive as Ms Robbins’ rating on the target scale, suggesting he ought to obtain therapy with a VMAT2. Nevertheless, all 5 of Mr Jones’ scores had been 2s, placing all of them within the gentle vary. As well as, he expressed no misery or issues in regards to the actions. After reviewing the doable impression of the present actions on numerous points of his each day functioning, he most well-liked to easily enhance monitoring.
Alternatively, Ms Robbins had a a lot decrease rating. But, she expressed that the average eye blinking and gentle lip actions had been impacting her job, feelings, vanity, and social functioning, inflicting important misery, so she readily agreed to provoke VMAT2 inhibitor therapy to attenuate these actions to the best diploma doable.
Domains of Impairment
These previous 8 years have proven us that TD is a a lot bigger bucket of signs than we initially thought. Though sufferers with extreme TD are readily recognizable, our problem is figuring out sufferers with average to gentle impairment. This requires the vigilance of a scientific AIMS examination. The clinician ought to make sure the affected person is relaxed and may pay attention to numerous activating maneuvers, corresponding to tapping every finger to the thumb of 1 hand whereas searching for actions in all places else.
As soon as actions are recognized, the true detective work begins. As a result of every individual is exclusive, actions that trouble one individual could also be hardly noticeable in one other, as within the circumstances of Ms Robbins and Mr Jones. Thus, as clinicians, we must always ask inquiries to uncover any diploma of purposeful impairment. Spouses, companions, household, mates, and care suppliers will be crucial to capturing the total vary of impairments. Importantly, some sufferers with anosognosia will innocently deny any actions regardless of dramatic TD with important impairments.
In 2022, a panel of TD specialists developed a standardized device that might be utilized simply in a scientific setting to evaluate TD’s impression on functioning in numerous domains. The ensuing Affect-TD scale measures the diploma of purposeful impression on 4 classes: social, psychological/psychiatric, bodily, vocational/instructional/leisure.9 Via my years of assessing and treating TD, I developed an acronym—MEASO—that has been useful in reminding me to ask the numerous inquiries to seize purposeful impairment ensuing from TD, whatever the AIMS rating or my impression of the seemingly penalties of the dyskinetic actions (Determine).
FIGURE. MEASO: Assessing Purposeful Impairment
Concluding Ideas
Antipsychotic drugs have confirmed to be worthy instruments in addressing psychiatric sickness, but they put our sufferers in danger for growing TD. Looking back, it isn’t stunning that psychiatry has neglected, and even turn into complacent, in finishing motor assessments, purposeful assessments, knowledgeable consent discussions, psychoeducation, and complete therapy of TD. The primary activity is to grasp the differential diagnoses of any movement-related symptom, then assess purposeful impression. When dealing with uncertainty, think about consulting with a psychiatric colleague or a neurologist to help within the differential prognosis and therapy. Importantly, as soon as the prognosis of TD has been made, carry out a radical evaluation of the ensuing purposeful impairment and work together with your affected person to seek out the outcomes which can be most applicable for them.
Dr Miller is Medical Director, Mind Well being, Exeter, New Hampshire; Editor in Chief, Psychiatric Instances; Workers Psychiatrist, Seacoast Psychological Well being Heart, Exeter; Consulting Psychiatrist, Perception Meditation Society, Barre, Massachusetts.
References
1. Griffiths Okay, Received Y, Lee Z, et al. Figuring out the diagnostic hole of tardive dyskinesia: an evaluation of semi-structured digital well being report knowledge. BMC Psychiatry. 2025;25(1):407.
2. Schonecker M. Paroxysmal dyskinesia because the impact of megaphen. Nervenarzt. 1957;28(12):550-553.
3. Correll CU, Kane JM, Citrome LL. Epidemiology, prevention, and evaluation of tardive dyskinesia and advances in therapy. J Clin Psychiatry. 2017;78(8):1136-1147.
4. Austedo/AustedoXR. Prescribing data. Teva Prescription drugs; 2025. https://www.austedo.com/globalassets/austedo/prescribing-information.pdf
5. Ingrezza. Prescribing data. Neurocrine Biosciences Inc; 2025. https://pi.neurocrine.com/ingrezza/INGREZZA-Full-Prescribing-Info.pdf
6. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Affiliation follow guideline for the therapy of sufferers with schizophrenia. Am J Psychiatry. 2020;177(9):868-872.
7. Miller JJ. Everybody please cease (EPS). Psychiatric Instances. 2022;39(8)4-5,25.
8. Man W. ECDEU Evaluation Handbook for Psychopharmacology, revised version. US Division of Well being, Schooling, and Welfare; 1976:534-537.
9. Jackson R, Brams MN, Carlozzi NE, et al. Affect-Tardive Dyskinesia (Affect-TD) Scale: a scientific device to evaluate the impression of tardive dyskinesia. J Clin Psychiatry. 2022;84(1):22cs14563.
